Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

34.66
Delayed Data
As of Jun 27
 -1.72 / -4.73%
Today’s Change
21.19
Today|||52-Week Range
60.79
-35.56%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close36.38
Today’s open35.94
Day’s range33.96 - 37.20
Volume674,419
Average volume (3 months)529,026
Market cap$1.6B
Dividend yield--
Data as of 06/27/2016

Growth & Valuation

Earnings growth (last year)-171.96%
Earnings growth (this year)-10.44%
Earnings growth (next 5 years)--
Revenue growth (last year)-84.17%
P/E ratioNM
Price/Sales21,235.50
Price/Book3.30

Competitors

 Today’s
change
Today’s
% change
HCMHutchison China Medi...-0.28-2.08%
TXMDTherapeuticsMD Inc-0.08-0.96%
IRWDIronwood Pharmaceuti...-0.06-0.49%
GWPHGW Pharmaceuticals P...+5.18+6.22%
Data as of 06/27/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.79
Annual revenue (last year)$91.4K
Annual profit (last year)-$104.8M
Net profit margin-114,698.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs